FDA Approved: ATOVAQUONE ORAL SUSPENSION — Original Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approved a generic version of atovaquone oral suspension (KVK-Tech, Inc.) via Original Application (ANDA210510).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Babesiosis
• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• ATOVAQUONE ORAL SUSPENSION (Atovaquone oral suspension)

Snippet

ORIG AP for ATOVAQUONE ORAL SUSPENSION (ATOVAQUONE)